Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-008615
Filing Date
2022-04-15
Accepted
2022-04-15 20:00:03
Documents
1
Period of Report
2022-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3668
  Complete submission text file 0001567619-22-008615.txt   4983
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 320 W 37TH STREET, 3RD FLOOR NEW YORK NY 10016
Business Address
Yanchik Connealy Pamela (Reporting) CIK: 0001796310 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 22830877